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INTRODUCTION 
Consumption of large amounts of alcohol is known to 
have negative effects, but drinking smaller amounts may 
have a protective effect in adults of all ages. Since alcohol is 
distributed in body water, a given dose of alcohol will have a 
greater pharmacokinetic effects in the elderly because of 
their diminished body water compared to younger adults.
1 
Elderly show markedly consistent pharmacodynamic profile 
reflecting early peak impairment and rapid acute tolerance,
2 
in conjunction with less pharmacodynamic sensitivity.
3 These 
suggest that alcohol consumption may have a greater affect 
on the elderly than on younger adults, particularly in relation 
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to cognitive function.
1 However, the systemized reviewed lit-
eratures concerning the optimum pattern of alcohol consump-
tion to protect against dementia and cognitive decline in the 
elderly have been relatively lacking.
The influence of alcohol on health varies depending on the 
amount consumed, drinking duration, type of alcohol and 
frequency, environmental factors, and the genetic disposition 
of the individual. Low to moderate drinking (LMD) may be 
helpful for stress relief, relaxation, mood elevation, intimacy 
formation, and cognitive function.
4-7 Furthermore, LMD 
may decrease the risk of cardiovascular disease (CVD), re-
spiratory disease, stroke, and mortality.
8-10 However, frequent 
heavy drinking or binge drinking may cause CVD, cancer 
and early death and is associated with alcohol abuse, intoxi-
cation, alcohol withdrawal, alcohol withdrawal delirium, al-
cohol dependence, alcohol-related cognitive impairment, 
and alcohol-related dementia (ARD), which may lead to severe 
social, economic, physical, and psychological burdens.
11-14 
Moreover, excessive alcohol consumption may induce organic 
changes in the region of the frontal cortex primarily involved in 
cognition and inhibitory control; thus, the relationship between 
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alcohol, cognition, and changes in frontal cortex structure have 
recently become the focus of clinical and neurobiological in-
terest.
12,15-17
During the normal ageing process, deficits in frontal cortex 
function (including working memory, speed of information 
processing, decision-making, planning, and judgment) or re-
trieval of stored memory may appear, and the decline of seman-
tic memory and verbal or crystallized intelligence is not clear.
18 
In addition to the effects of the normal aging process, the risk 
or prevalence of mild cognitive impairment and dementia ap-
pears to increase with age in the elderly.
12,19,20 At present, no 
cure for dementia or therapeutic strategy to prevent the transi-
tion of mild cognitive impairment to dementia exist, but epide-
miological evidence supports the hypothesis that a healthy life-
style may prevent the development dementia in the elderly.
18,21,22 
Healthy life habits associated with a reduction in the risk of de-
mentia are exercise, physical activity, healthy diet, and LMD.
23-25 
The type of alcohol and optimal level of consumption associat-
ed with a healthy lifestyle are not well understood, and studies 
of LMD and health often have methodological limitations, such 
as confounding effects of gender, racial/cultural differences, and 
comorbidities such as depression and substance use disorders. 
Thus, the outcomes of studies related to LMD are controversial 
and systematic reviews of evidence-based research are necessary. 
The present review of evidence-based research may help de-
termine the optimal alcohol drinking pattern to prevent cogni-
tive decline and dementia in the elderly and provide an alterna-
tive to existing therapeutic interventions, which have limited 
effectiveness. Accordingly, the present paper is a review of the 
literature focusing on the influence of alcohol on cognition and 
dementia in the elderly. We searched the NCBI PubMed data-
base (available at http://www.ncbi.nlm.nih.gov) within the last 
10 years (2001 to 2011) using the key words: alcohol, ethanol, 
cognition, neuroprotection, neurotoxicity, elderly, mild cogni-
tive impairment, and dementia. In some cases, earlier studies 
from the reference lists of relevant papers (1971 to 2000) were 
reviewed. 
The authors first reviewed the neurotoxic effects of alcohol 
in the elderly with a focus on cognitive function and changes to 
brain structure related to psychiatric symptoms and disorders. 
We then reviewed the neuroprotective effect of alcohol on cog-
nitive function and related changes to brain structure in the el-
derly with a focus on the optimal pattern and level of alcohol con-
sumption to prevent cognitive dysfunction. 
NEUROTOXIC EFFECT OF ALCOHOL
Mechanism of alcohol neurotoxicity
The brain is highly vulnerable to the neurotoxic effects of al-
cohol, and cognitive disorders may result from brain damage 
caused by chronic alcohol abuse.
26 The neurotoxic effects of al-
cohol that cause cognitive deficits may be mediated directly 
through damage to brain structures or indirectly through mal-
nutrition, metabolite toxicity, electrolyte imbalance, or accom-
panying physical illnesses including liver disease and infection.
27 
The direct neurotoxic effect of alcohol is mediated via its action 
on the NMDA receptors of glutamatergic neurons. Acute alco-
hol intake exerts an inhibitory effect on NMDA receptors and, 
thus, induces receptor up-regulation, but when alcohol intake 
ceases, the up-regulated receptors are no longer inhibited, result-
ing in an excessive stimulation of NMDA receptors. This, in turn, 
causes an excessive influx of calcium with cytotoxic effects.
26 Glu-
tamatergic neurons are densely concentrated in the frontal 
lobes and subcortical areas such as the hippocampus, and these 
brain regions are particularly vulnerable to excitotoxic effects 
produced by alcohol intake.
26 Thiamine deficiency and Korsa-
koff syndrome resulting from chronic alcohol abuse is an exam-
ple of indirect alcohol neurotoxicity. Thiamine deficiency causes 
an excessive release of glutamate which, like alcohol, can exert 
a neurotoxic effect; in fact, chronic alcohol abuse and thiamine 
deficiency may have an additive or even synergistic neurotoxic 
effect.
28 Studies of amnesia in patients with Korsakoff syndrome 
have shown that the condition may have an anterograde com-
ponent with inability to learn new information, and a retrograde 
component in which the recent memory is more impaired than 
remote memory, and a confabulation component associated 
with these memory defects.
29 The apolipoprotein E (APOE) 
epsilon 4 allele provides a possible genetic explanation for sus-
ceptibility to alcohol-induced neurotoxicity. Research findings 
suggest that people with the allele have a less effective neural re-
pair mechanism and, thus, are more susceptible to the deleteri-
ous effects of alcohol.
30,31 Elevated serum levels of homocyste-
ine is related to alcoholism,
32 and leads to increase of glutama-
tergic neurotransmission via overstimulation of NMDA re-
ceptors.
33 This plays a crucial role in the neurobiology of al-
coholism, particularly regarding cognitive impairment,
34 brain 
atrophy,
35 and alcohol withdrawal seizures.
36 Regarding to al-
cohol neurotoxicity related to immune system, it is reported 
that chronic alcohol induces systemic cytokines particularly tu-
mor necrosis factor alpha (TNF α). TNF α appears to involve po-
tentiation of glutamate excitotoxicity and activates resident mi-
croglia inducing neuroinflammation.
37 There are the recent fin-
dings in micoglia and astrocyte function toward neurotoxicity 
via reactive oxygen species under heavy alcohol consumption.
37-40 
Taken together, alcohol disruption of cytokines and inflamma-
tion contribute in multiple ways to a diversity of alcoholic neu-
rotoxicity. 
Other mechanisms that may influence alcohol-related neu-
rotoxcity and cognitive dysfunction are free radical toxicity, ac-
etaldehyde toxicity, modulation of the nicotinic acetylcholine 10  Psychiatry Investig 2012;9:8-16
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receptor, serotonin receptor, dopamine receptor, opioid recep-
tor, and gamma-aminobutyric acid (GABA) receptor, but ad-
ditional studies are necessary to confirm these findings.
41-44 
Acute effect of heavy drinking on cognition 
The common symptoms of acute alcohol neurotoxicity in-
clude cognitive impairment, blackout, and hangover. Heavy or 
binge drinking commonly causes acute alcohol intoxication, 
and blackouts may occur without loss of consciousness in this 
state.
45 After the intoxication has worn off, headache, dysphor-
ic mood, tremor, fatigue, vomiting, loss of appetite, and diarrhea 
and gastrointestinal symptoms may persist for a considerable 
amount of time in the hangover.
46 Blackouts and hangovers oc-
cur prior to alcohol-related cognitive dysfunction and are clini-
cally significant as predictive factors for brain damage that may 
cause transient cognitive impairment or more permanent cog-
nitive dysfunction.
47,48
Alcohol intoxication during or after heavy alcohol consump-
tion causes clinically maladaptive behavioral changes and physi-
ological changes that may lead to impaired judgment, memory 
and attention damage, stupor, or coma.
49 Impairment in free re-
call, executive function, and visuospatial function are clearly ob-
served at all ages in the state, and most of these symptoms are 
reversible after alcohol withdrawal.
50,51 
A blackout may be complete (en-bloc) or partial (fragmen-
tary) depending on the severity of memory impairment,
52 and 
is related to impaired episodic memory, a type of memory en-
coded using spatial and social contexts.
53 Blackout is most con-
sistently associated with a rapid increase in blood alcohol con-
centration. However, not all people who drink rapidly and ex-
cessively experience blackouts, suggesting that genetic dis-
position plays a role in determining brain vulnerability to 
alcohol. Alcohol-related blackouts may disturb the memory 
stages of encoding, storage, and retrieval (recall, recognition), 
and cause complete or partial deficits in retrieval. Blackouts 
may result from damage to the hippocampus which is involved 
in encoding memory at the cellular level, and antagonization 
of the N-methyl D-aspartate (NMDA) receptors which are nec-
essary for the induction of long-term potentiation in the hippo-
campus at the molecular level.
54
Hangovers from alcohol intoxication are generally the result 
of binge drinking. Studies investigating the relationship between 
hangover and cognitive deficits have reported conflicting or 
negative results. This disparity may be the result of methodolog-
ical differences involving the definition of hangover, alcohol 
dose, state (e.g., quality of sleep, mood, and uncontrolled behav-
ior), type of tasks, and time of assessment after alcohol intake. 
However, recent studies using complex tasks to assess cognitive 
function when the level of alcohol were 0 found a decline in 
memory, attention, psychomotor performance, and frontal ex-
ecutive function during hangover. Further studies are necessary 
to verify these effects of hangover on cognition.
55
Cognitive decline in low to moderate drinking 
Ryback
56 proposed a continuum of alcohol effects on cog-
nition from light functional deterioration in LMD to serious 
cognitive deficits in heavy drinkers. Consistent with this hy-
pothesis, early studies found cognitive deficits in abstraction 
and concept formation in young-to middle-aged men who en-
gaged in social drinking,
57,58 and two studies in women report-
ed similar results.
59,60 Two previous studies reported that LMD 
increased cognitive decline in the elderly,
61,62 and one longitu-
dinal study reported that LMD increased the risk of Alzheim-
er’s disease.
63 A population-based study suggested that elderly 
low to moderate drinkers who were APOE epsilon 4 allele car-
riers were more likely to develop dementia compared with non-
drinking and non-carrier counterparts.
30 
Effect of low to moderate alcohol intake 
on brain structures
Increased brain shrinkage with a linear increase in ventricle 
size and sulci width has been reported in middle-aged
64 and el-
derly
65 chronic low to moderate drinkers according to the amount 
of alcohol consumed. Furthermore, a linear increase in white 
matter volume and decrease in grey matter volume in the fron-
tal and parietal brain regions has been reported in middle-aged 
men who were chronic low to moderate drinkers.
66 
Alcohol-Related Dementia in heavy drinking 
The relationship between dementia and alcohol use is com-
plex. Chronic heavy drinking may cause brain damage and give 
rise to ARD, a form of dementia that is clinically different from 
Alzheimer’s disease and vascular dementia.
67 The concept of 
ARD is now recognized as Alcohol-Induced Persisting Demen-
tia in the Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-IV, and its diagnostic criteria must fulfill conditions such 
as alcohol-related multiple cognitive deficits that may cause sig-
nificant impairment in social or occupational functioning, com-
pared with the previous level of functioning. Furthermore, the 
symptoms cannot occur just during the course of delirium and 
must persist beyond the usual duration of substance intoxica-
tion or withdrawal.
49 This diagnosis, however, has been made 
entirely at the discretion of the clinician, and considerable con-
troversy exists as to its clinical validity as a diagnostic entity.
68 
Oslin et al.
14 suggested that the ARD diagnostic criteria be sub-
divided into probable ARD, possible ARD, and mixed demen-
tia modeled after the National Institute for Neurological and 
Communicative Disorders and Stroke and the Alzheimer’s Dis-
ease and Related Disorder Association (NINCDS/ADRDA) di-
agnostic criteria for Alzheimer’s disease. In a subsequent study, JW Kim et al. 
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Oslin et al.
67 independently verified the validity of these diag-
nostic criteria and reported that 24% of dementia patients had 
ARD and 10% of elderly nursing home residents were diagnosed 
with ARD. These diagnostic criteria continue to be widely used; 
however, consensus regarding their usefulness has not been 
reached, and further research is warranted.
The diagnostic algorithm developed by the authors (JWK and 
DYL) to facilitate the clinical diagnosis of ARD
14 contains seven 
‘yes’ or ‘no’ questions and is described as follows: 1) Is it demen-
tia? (Dementia is defined as a significant deterioration of cog-
nitive function sufficient to interfere with social or occupational 
functioning. As defined by DSM-IV,
49 this requires deteriora-
tion in memory and in at least one other area of intellectual func-
tioning. Moreover, the cognitive changes cannot be attributable 
to the presence of delirium or substance-induced intoxication 
or withdrawal.) 2) Was the clinical diagnosis of dementia made 
at least 60 days after the last exposure to alcohol? 3) Was there 
significant alcohol use as defined by a minimum average of 35 
standard drinks (SD) per week for men or 28 for women over 
a period greater than 5 years? [If ‘yes‘, go to question 5, if ‘no’ go 
to question 4] 4) Was there significant alcohol use as defined by 
an average of 21-34 SD per week for men and 14-27 for wom-
en over a period greater than 5 years? 5) Did the period of sig-
nificant alcohol use occur within 3 years of the initial onset of 
dementia? [If ‘yes‘, go to question 7, if ‘no’, go to question 6] 6) 
Did the period of significant alcohol use occur 3-10 years prior 
to the initial onset of dementia? 7) Is there more than one cause 
for the dementia? The diagnostic interpretation of the algorithm 
is as follows. If the answer to questions 1, 2, 3, 5 is ‘yes’, the di-
agnosis is probable ARD. If the answer is ‘yes’ to questions 1, 2, 
3, 6 or to 1, 2, 4, 5, the diagnosis is possible ARD. Finally, if the 
answer to questions 1 and 7 are ‘yes’, mixed dementia is diag-
nosed. A diagnosis of ARD is supported by the presence of any 
of the following: 1) alcohol-related hepatic, pancreatic, gas-
trointestinal, cardiovascular, or renal disease, or other end-or-
gan damage; 2) ataxia or peripheral sensory polyneuropathy (not 
contributable to other specific causes); 3) the cognitive impair-
ment stabilizes or improves after 60 days of abstinence; 4) neu-
roimaging evidence of ventricular or sulcal dilatation improves 
after 60 days of abstinence; 5) neuroimaging evidence of cere-
bellar atrophy, particularly in the vermis.
14,67 
Several recent cohort and epidemiological studies using vary-
ing diagnostic criteria in people over 65 years of age have report-
ed a high incidence of comorbid excessive alcohol intake and 
dementia or the increased risk of dementia and severe cognitive 
impairment.
67,69-72 In people diagnosed with ARD, the cognitive 
deficit manifests as poor working memory, decreased verbal flu-
ency, perseveration, circumstantiality, impaired abstraction, and 
decreased behavioral initiation,
73 and magnetic resonance im-
aging (MRI) scans show ventricular enlargement and diffuse at-
rophy disproportionately affecting the prefrontal regions.
74,75 
These neuropsychological deficits and brain damage may be 
partially reversed with continued abstinence.
76-78
Marchiafava-Bignami disease in heavy drinking
Marchiafava-Bignami disease (MBD) is a rare toxic disease 
commonly found in chronic alcoholics. The exact cause is not 
known, but progressive demyelination of the corpus callosum 
is the pathological hallmark of this condition and anatomical 
pathology examination reveals demyelination and necrosis of 
the corpus callosum.
79 Clinically, this disease may start with stu-
por or coma. Upon recovery, seizure, dementia with complex 
attention deficits, memory and language difficulty, personality 
change, and signs of interhemispheric disconnection (e.g., left-
hand anomia, apraxia, agraphia) may appear.
80,81
NEUROPROTECTIVE EFFECT  
OF ALCOHOL
Mechanism of alcohol neuroprotection
Several studies showing a lower risk of CVD in LMD com-
pared with non-drinkers or heavy drinkers suggest a neuropro-
tective effect of alcohol.
82,83 This cardioprotection has been at-
tributed, in part, to an alcohol-induced elevation of high density 
lipoprotein cholesterol (HDL-cholesterol),
84 reduction of fibrin-
ogen and other thrombotic factors,
85-87 and reduction in the in-
flammatory marker C-reactive.
88 Furthermore, work in animals 
has shown that the neuroprotective effect is linked to interactions 
between alcohol and protein kinase C, the adenosine receptor, 
and cardioprotective proteins (e.g., superoxide dismutase, nitric 
oxide synthase, and heat shock protein). Moreover, the findings 
indicated that neuroprotection is correlated with the down-regu-
lation of inducible nitric synthase and up-regulation of endothe-
lial nitric oxide synthase.
86 Furthermore, a study in animals show-
ed that ingestion of low to moderate levels of alcohol prior 
ischemic stroke protected against ischemia-induced brain dam-
age by delaying neuronal death, neuronal and dendritic degen-
eration, oxidative DNA damage, glial cell activation, and neu-
trophil infiltration.
89 In addition to the antioxidant properties 
of alcohol itself, the antioxidant effect of polyphenols (such as 
resveratrol), which are abundant in red wine, has been proposed 
to be neuroprotective.
90-92 Moreover, low to moderate alcohol in-
take has been shown to act on cholinergic fibers in rats to stim-
ulate prefrontocortical acetylcholine release.
93
The evidence strongly suggests that LMD acts via these neu-
roprotective mechanisms and benefits the brain and cardiovas-
cular system by protecting against myocardial infarction, isch-
emic stroke, cognitive decline, vascular dementia, and Alzhei-
mer’s disease.
9412  Psychiatry Investig 2012;9:8-16
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Effect of low to moderate alcohol consumption 
on cognition
Studies of the influence of LMD on cognition have reported 
varying results. Several earlier studies suggested that LMD did 
not decrease the risk of cognitive decline, including dementia;
95-98 
however, most of those studies had methodological limitations, 
such as cross-sectional design, small sample size, uncontrolled 
confounding factors, and variability in age, gender, and type of 
alcohol. Furthermore, LMD may be a proxy marker that re-
flects psychiatric and physical health and socio-economical 
position, and may be related to cognitive functions other than 
the mechanism that improves the vascular system described 
above;
99 thus, caution is required in the evaluation of the rela-
tionship between alcohol consumption and cognition.
An increasing number of reports suggest a U- or J-shaped rela-
tionship between cognitive function and amount of alcohol con-
sumption, suggesting that LMD is more beneficial to cognition 
than non-drinking or heavy drinking.
65,100-102 In contrast, sever-
al studies have reported limited or condition-specific benefits of 
alcohol on cognitive function. Launer et al.
103 found that alco-
hol improved cognitive function only in patients with CVD or 
diabetes mellitus, while other studies have reported a benefit in 
elderly women, but not men.
104,105 Studies of the neuroprotec-
tive effect of the APOE epsilon 4 allele have reported neuropro-
tection in the presence of the allele,
100,106 in the absence of the 
allele,
94,107 and no effect in either its presence or absence.
6,108
In recent cross-sectional population-based studies of Afri-
can Americans,
70 French men and women,
105 Japanese Ameri-
can,
109 LMD was found to have a greater cognitive benefit than 
non-drinking. Moreover, six large-scale longitudinal popula-
tion-based studies reported similar results.
6,108,110-113 According 
to a recent meta-analysis of 23 longitudinal studies (20 epide-
miology cohort studies and three retrospective matched case-
controls nested in a cohort) of alcohol consumption and cog-
nitive decline or dementia in elderly people over 65 years of age, 
LMD significantly reduced the risk of dementia [risk ratio (RR) 
0.63; 95% CI 0.53-0.75] and Alzheimer’s disease (RR 0.57; 0.44-
0.74) and showed a non-significant trend in reducing vascular 
dementia (RR 0.82; 0.50-1.35) and cognitive decline (RR 0.89; 
0.67-1.17).
114
Effect of low to moderate alcohol intake 
on brain structures
MRI results have revealed that chronic LMD may cause brain 
shrinkage,
64,65 an increase in white matter volume, and a reduc-
tion in grey matter volume;
66 however, a recent study has report-
ed partially conflicting results showing less white matter dam-
age in elderly low to moderate drinkers compared with non-
drinkers.
26 Furthermore, a U- or J-shaped relationship between 
alcohol consumption and an increase in brain volume was found 
in elderly women who were light drinkers (<7 SD per week) rel-
ative to abstainers.
115 Two studies reported no change in white 
and grey matter volume as a function of amount of alcohol con-
sumed in middle-aged women relative to middle-aged men.
66,116 
These gender differences can be explained by the protective 
effect of estrogen against glutamate toxicity.
66 Elderly men who 
were low to moderate drinkers showed a reduction in white mat-
ter hyperintensity and an increase in grey matter volume in a 
U- or J-shaped pattern when compared with abstainers, and el-
derly women showed no change in either white or grey matter.
115 
Studies of white matter grade, which evaluate the degree of cor-
tical white matter integrity, have reported no significant neuro-
protective effect of LMD on white matter grade in men and 
women (middle-aged adults and older adults of 60-64years old) 
under 65 years of age.
64,115 However, a U- or J-shaped pattern be-
tween white matter grade and alcohol consumption has been 
reported in elderly LMDs over 65 years of age.
65,117 Although 
studies of the relationship between LMD and changes in brain 
structure show varying results, overall, the evidence suggests 
that alcohol has a neuroprotective effect in the elderly.
26
Optimal alcohol consumption and type 
The size and amount of alcohol contained in a SD differs from 
country to country, and no standard definition of LMD exists; 
thus, studies examining the cognitive benefits of LMD often have 
varying results. It is, therefore, critical that LMD and SD be stan-
dardized for future studies.
A recent systematic review using a meta-analysis to investi-
gate optimal alcohol consumption to prevent cognitive decline 
in the elderly found no agreement on the optimal drinking pat-
tern because the classification of LMD varied widely.
114 Reports 
of the optimal consumption against cognitive decline in the el-
derly ranged from more than, less than, or equal to one drink a 
month
113 or one drink a day,
118 and one to two drinks per week 
in subjects with CVD or diabetes.
103 The optimal amount report-
ed against Alzheimer’s disease was weekly consumption of wine,
119 
one to six or more than two drinks per week,
94,120 or more than 
three drinks/250-500 mL per day (usually wine),
121 or when 
studied by gender, one to three drinks per day in men.
100,120,121 
Against dementia, benefit was shown with more than one drink 
per day, weekly, or monthly wine consumption, 250-500 mL 
(usually wine) or more than three drinks per day
118,120-122 and 
from 1-28 units per week.
123 One to three drinks per day appeared 
to be beneficial for men against vascular dementia.
100
With regard to the alcohol type, the review of longitudinal 
studies on the influence of alcohol on cognitive function showed 
that there are mainly reports of cognitive benefit in wine,
121,122 
and there are reports of cognitive benefit regardless of alco-
hol type.
6,94,108 
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CONCLUSIONS
Heavy or binge drinking has neurotoxic effects regardless of 
age. Alcohol consumption may have a greater affect on the el-
derly via its pharmacological effects and ageing process than 
on younger adults, particularly in relation to cognitive function. 
Longitudinal and brain imaging studies in the elderly show 
that excessive alcohol consumption may increase the risk of cog-
nitive dysfunction and dementia, but LMD may protect against 
cognitive decline and dementia and provide cardiovascular ben-
efits. Evidence suggesting that LMD in the elderly protects 
against cognitive decline and dementia exists. The present re-
view of evidence-based research may help determine the opti-
mal alcohol drinking pattern to prevent cognitive decline and 
dementia in the elderly and provide an alternative to existing 
therapeutic interventions, which have limited effectiveness. 
However, the varying results of several evidence-based studies 
of the benefits and risks of alcohol on cognition should be in-
terpreted with caution. Furthermore, the cognitive benefit of 
LMD may vary from person to person; thus, it is difficult to 
make a clinical recommendation for abstainers to drink alco-
hol. Nevertheless, it is important to conduct well-designed stud-
ies to determine the optimal alcohol drinking pattern for the el-
derly as the alternative against cognitive decline and dementia.
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